Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 28.
 Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2013.11.14. 11:32:57   Á¶È¸: 4240
2013³â 11¿ù 10ÀÏ~13ÀϱîÁö ÀϺ» ¿À»çÄ«, ¿À»çÄ«±¹Á¦È¸ÀÇÀå¿¡¼­ Á¦12Â÷ ±¹Á¦ÀÌÁ¾À̽ÄÇÐȸ Çмú´ëȸ°¡ ¼ºÈ²¸® °³ÃֵǾú´Ù.
Âü°¡ÀÚµéÀº Àü¼¼°è¸¦ Æ÷ÇÔÇÏ¿© ¹Ì±¹, À¯·´, È£ÁÖ, ´ºÁú¶õµå, Áß±¹, ÀϺ», Çѱ¹µî¿¡¼­ ¾à 400 ¿©¸íÀÇ ÀÌÁ¾À̽Ŀ¬±¸ °ü·ÃÇÐÀÚµéÀÌ 4ÀÏ°£ 400 ¿©ÆíÀÇ ÀÌÁ¾À̽İü·Ã ¿¬±¸¹ßÇ¥¿Í Ư°­, ½ÉÆ÷Áö¿òµîÀ¸·Î ¿­¶í Çмú´ëȸ°¡ ÁøÇàµÇ¾ú´Ù.
Çѱ¹¿¡¼­µµ ¿©·¯´ëÇп¡¼­ ¸¹Àº ¿¬±¸ÁøÀÌ Âü¼®ÇÏ¿´À¸¸ç ÃÊû°­¿¬, ¿¬±¸¹ßÇ¥¸¦ ½ÃÇàÇÏ¿´´Ù. ƯÈ÷ ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¬±¸ÁøÀÌ Çѱ¹ ´ëÇ¥µéÀÇ ÁÖ·ù¸¦ ÀÌ·ç°í ÃÊû°­ÀÇ, ÁÂÀå, ½Ê¿©ÆíÀÇ ¿¬±¸°á°ú¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ¼­¿ï´ëÇб³º´¿ø ÈäºÎ¿Ü°ú¿¡¼­µµ  Development of novel combined anticalcification protocol including immunologic modification for prolonged durability of cardiac xenograft in animal study¿Í In-vivo efficacy for treatment with decellularization, alpha-galactosidase, spacefiller, organic solvent and detoxifixation of GA-fixed cardiac xenograft using alpha-gal mouse implantation model À̶õ ¿¬Á¦¸¦ ¹ßÇ¥ÇÏ¿´´Ù. ±Ý³â¿¡´Â alpha-gal KO pig¿¡ genetic modification ÁøÇàÀÌ ´õ¿í ÇöÀúÇÏ°í, genetically induced disease(agenesis) model°³¹ß, chimerism ¹æ¹ýµµ ´«ºÎ½Ã°Ô ¹ßÀüµÇ¾ú´Ù. Çѱ¹µµ ÀÌ·¯ÇÑ ÀÌÁ¾À̽Ŀ¡¼­ À¯ÀüÀÚ Ã³¸® ±â¼úµéÀÌ »¡¸® Çâ»óµÇ±æ ±â¿øÇÑ´Ù.
LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 28.  Àüü±Û: 211  ¹æ¹®¼ö: 1028526
71 Áß±¹ ÇϾóºó ¾Æµ¿º´¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2008.04.13.4166
70 Á¦ 16Â÷ ¾Æ½Ã¾Æ½ÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ ±è¿ëÁø2008.03.17.4257
69 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.11.30.4558
68 Áß±¹ »êµ¿¼º Áö³­ õºÒ»êº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.11.19.5352
67 ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.10.29.5706
66 ÀÌÁ¾ ÆǸ·°³¹ß ¿¬±¸¼¼¹Ì³ª °ü¸®ÀÚ2007.10.29.4773
65 Á¦ 10Â÷ ¼Ò¾Æ½ÉÀå ½ÉÆ÷Áö¿ò °ü¸®ÀÚ2007.08.31.4415
64 Áß±¹ Áß°æ½Ã Á߻꺴¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.08.16.4815
63 Áß±¹ ÇϾóºó¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.06.25.4823
62 Áß±¹ ¿¬±æ º¹Áöº´¿ø½ÉÀå¼ö¼ú °ü¸®ÀÚ2007.06.25.4772
RELOAD WRITE
 1 ¢¸ [11] [12] [13] [14] 15 [16] [17] [18] [19] [20]  ¢º 22